Physician profile
Christopher J Bender
NPI 1124284906
$538.43
in general payments reported to CMS, 2019-2025
15 companies · $23.92 in 2025
The $23.92 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $134 · 2020: $19.66 · 2021: $61.47 · 2022: $59.58 · 2023: $145 · 2024: $95.11 · 2025: $23.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $263.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $143.47 | 2019-2025 | |
| Seqirus USA INC | $58.62 | 2023-2024 | Flucelvax Quadrivalent, Flucelvax |
| Kaleo, INC. | $41.12 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $38.23 | 2023-2024 | Flumist Quadrivalent |
| Sanofi Pasteur INC. | $37.84 | 2021 | |
| Merck Sharp & Dohme LLC | $34.41 | 2023-2024 | Vaxneuvance, Gardasil 9, Gardasil |
| Genentech USA, INC. | $31.79 | 2020-2021 | |
| Sobi, INC | $28.09 | 2019 | |
| Verrica Pharmaceuticals INC. | $22.50 | 2024 | Ycanth |
| Corium, LLC | $20.65 | 2022 | |
| Amneal Pharmaceuticals LLC | $19.74 | 2019 | |
| Cranial Technologies, INC | $19.29 | 2023 | Doc Band |
| Alk-Abello, INC | $16.75 | 2023 | Odactra, Grastek, Ragwitek |
| Ironshore Pharmaceuticals INC. | $14.43 | 2023 | Jornay Pm |
| Cumberland Pharmaceuticals, INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bender listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.